Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-m9kch Total loading time: 0 Render date: 2024-05-01T12:50:40.212Z Has data issue: false hasContentIssue false

25 - Four patients in an osteoporosis clinic

Published online by Cambridge University Press:  06 December 2010

Judith C. Ahronheim
Affiliation:
State University of New York, Downstate Medical Centre
Zheng-Bo Huang
Affiliation:
Cornell University, New York
Vincent Yen
Affiliation:
New York Medical College
Christina Davitt
Affiliation:
Seton Hall University, New Jersey
David Barile
Affiliation:
Drexel University, Philadelphia
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cummings, S. R., Palermo, L., Browner, W.et al. (2000). Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. Journal of the American Medical Association, 283, 1318–21CrossRefGoogle ScholarPubMed
Garnero, P., Sornay-Rendu, E., Claustrat, B.et al. (2000). Biochemical markers of bone turnover, endogenous hormones, and the risk of fractures in postmenopausal women: the OFELY study. Journal of Bone and Mineral Research, 15, 1526–36CrossRefGoogle ScholarPubMed
Kannus, P., Palvanen, M., Kaprio, J.et al. (1999). Genetic factors and osteoporotic fractures in elderly people: prospective 25 year follow up of a nationwide cohort of elderly Finnish twins. British Medical Journal, 319, 1334–7CrossRefGoogle ScholarPubMed
Morley, J. E. and Perry, H. M. (2003). Androgens and women at the menopause and beyond. Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 58, M409–16CrossRefGoogle ScholarPubMed
Neer, R. M., Arnaud, C. D., Zanchetta, J. R.et al. (2001). Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. New England Journal of Medicine, 344, 1434–41CrossRefGoogle ScholarPubMed
Nelson, H. D., Rizzo, J., Harris, E.et al. (2002). Osteoporosis and fractures in postmenopausal women using estrogen. Archives of Internal Medicine, 162, 2278–84CrossRefGoogle ScholarPubMed
Reginster, J. Y., Henrotin, Y., Christiansen, C.et al. (2001). Bone resorption in postmenopausal women with normal and low bone mineral density assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I. Calcified Tissue International, 69, 130–7CrossRefGoogle ScholarPubMed
Siris, E. S., Miller, P. D., Barrett-Connor, E.et al. (2001). Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. Journal of the American Medical Association, 286, 2815–22CrossRefGoogle ScholarPubMed
Adachi, J. D., Saag, K. G., Delmas, P. D.et al. (2001). Two year effects of alendronate on bone mineral density and vertebral fractures in patients receiving glucocorticoids. Arthritis and Rheumatism, 44, 202–113.0.CO;2-W>CrossRefGoogle Scholar
Amin, S., Zhang, Y., Sawin, C. T.et al. (2000). Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study. Annals of Internal Medicine, 133, 951–63CrossRefGoogle ScholarPubMed
Bai, J. C., Gonzalez, D., Mautalen, C.et al. (1997). Long term effect of gluten restriction on bone mineral density of patients with coeliac disease. Alimentary Pharamacology and Therapeutics, 11, 157–64CrossRefGoogle Scholar
Bauer, D. C., Ettinger, B., Nevitt, M. C.et al., for the Study of Osteoporotic Fractures Research Group (2001). Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Annals of Internal Medicine, 134, 561–8CrossRefGoogle ScholarPubMed
Bauer, D. C., Mundy, G. R., Jamal, S. A.et al. (2004). Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials. Archives of Internal Medicine, 164, 146–52CrossRefGoogle ScholarPubMed
Bone, H. G., Greenspan, S. L., McKeever, C.et al. (2000). Alendronate and estrogen effects in postmenopausal women with low bone density. Journal of Clinical Endocrinology and Metabolism, 85, 720–6Google Scholar
Canalis, E. (2003). Mechanisms of glucocorticoid-induced osteoporosis. Current Opinions in Rheumatology, 15, 454–7CrossRefGoogle ScholarPubMed
Cauley, J. A., Robbins, J., Chen, Z.et al. (2003). Effects of estrogen plus progestin on risk of fracture and bone mineral density. The Women's Health Initiative Randomized Trial. Journal of the American Medical Association, 290, 1729–38CrossRefGoogle ScholarPubMed
Cooper, C., Atkinson, E. J., O'Fallon, W. M.et al. (1992). Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985–1989. Journal of Bone and Mineral Research, 7, 221–7CrossRefGoogle Scholar
Cummings, S. R., Black, D. M., Thompson, D. E.et al. (1998). Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. Journal of the American Medical Association, 280, 2077–82CrossRefGoogle ScholarPubMed
Dawson-Hughes, B., Harris, S. H., Krall, E. A.et al. (1997). Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. New England Journal of Medicine, 337, 670–6CrossRefGoogle ScholarPubMed
Downs, R. W., Bell, N. H., Ettinger, M. P.et al. (2000). Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women. Journal of Clinical Endocrinology and Metabolism, 85, 1783–8Google ScholarPubMed
Ettinger, B., Black, D. M., Mitlak, B. H.et al., for the Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators (1999). Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. Results from a 3-year randomized clinical trial. Journal of the American Medical Association, 282, 637–44CrossRefGoogle ScholarPubMed
Ettinger, M. P. (2003). Aging bone and osteoporosis: strategies for preventing fractures in the elderly. Archives of Internal Medicine, 163, 2237–46CrossRefGoogle ScholarPubMed
Gregg, E. W., Cauley, J. A., Seeley, D. G.et al. (1998). Physical activity and osteoporotic fracture risk in older women. Study of Osteoporotic Fractures Research Group. Annals of Internal Medicine, 129, 81–8CrossRefGoogle ScholarPubMed
Hulley, S., Furberg, C., Barrett-Connor, E.et al. (2002). Noncardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II). Journal of the American Medical Association, 288, 58–66CrossRefGoogle Scholar
Kannus, P., Parkkaru, J., Niemi, S.et al. (2000). Prevention of hip fracture in elderly people with the use of a hip protector. New England Journal of Medicine, 343, 1506–13CrossRefGoogle ScholarPubMed
Kelepouris, N., Harper, K. D., Gannon, F.et al. (1995). Severe osteoporosis in men. Annals of Internal Medicine, 123, 452–60CrossRefGoogle ScholarPubMed
Klebzak, G. M., Beinart, G. A., Perser, K.et al. (2002). Undertreatment of osteoporosis in men with hip fracture. Archives of Internal Medicine, 162, 2217–22CrossRefGoogle Scholar
Lacroix, A. Z., Ott, S. M., Ichikawa, L.et al. (2000). Low-dose hydrochlorthiazide and preservation of bone mineral density in older adults. A randomized, double blind, placebo controlled trial. Annals of Internal Medicine, 133, 516–26CrossRefGoogle Scholar
Lanza, F. L., Hunt, R. H., Thomson, A. B.et al. (2000). Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women. Gastroenterology, 119, 631–8CrossRefGoogle ScholarPubMed
LeBoff, M. S., Kohlmeier, L., Hurwitz, S.et al. (1999). Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. Journal of the American Medical Association, 281, 1505–11CrossRefGoogle ScholarPubMed
Liberman, U. A., Weiss, S. R., Broll, J.et al. (1995). Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. New England Journal of Medicine, 333, 1437–43CrossRefGoogle Scholar
MacLaughlin, J. and Holick, M. F. (1985). Aging decreases the capacity of human skin to produce vitamin D3. Journal of Clinical Investigation, 76, 1536–8CrossRefGoogle ScholarPubMed
Manolagas, S. C. and Jilka, R. L. (1995). Bone marrow, cytokines, and bone remodeling. New England Journal of Medicine, 332, 305–11CrossRefGoogle ScholarPubMed
McClung, M. R., Geusens, P., Miller, P. D.et al., for the Hip Intervention Program Study Group (2001). Effect of risedronate on the risk of hip fracture in elderly women. New England Journal of Medicine, 344, 333–40CrossRefGoogle ScholarPubMed
Orwoll, E., Ettinger, M., Weiss, S.et al. (2000). Alendronate for the treatment of osteoporosis in men. New England Journal of Medicine, 343, 604–10CrossRefGoogle ScholarPubMed
Peh, W. C. G., Gilula, L. A., and Peck, D. D. (2002). Percutaneous vertebroplasty for severe osteoporotic vertebral body compression fractures. Radiology, 223, 121–6CrossRefGoogle ScholarPubMed
Reid, I. R., Ames, R. W., Evans, M. C.et al. (1993). Effect of calcium supplementation on bone loss in postmenopausal women. New England Journal of Medicine, 328, 460–4CrossRefGoogle Scholar
Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Food and Nutrition Board Institute of Medicine (1997). Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press, pp. 274–5
Tonino, R. P., Meunier, P. J., Emkey, R.et al. (2000). Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group. Journal of Clinical Endocrinology and Metabolism, 85, 3109–15Google ScholarPubMed
U.S. Preventive Services Task Force (2002). Screening for osteoporosis in postmenopausal women: recommendations and rationale. Annals of Internal Medicine, 137, 526–8CrossRef
Staa, T. P., Leufkens, H. G. M., and Cooper, C. (2001). Use of inhaled corticosteroids and risk of fractures. Journal of Bone and Mineral Research, 15, 993–1000CrossRefGoogle Scholar
Vogel, J. M., Davis, J. W., Nomura, A.et al. (1997). The effect of smoking on bone mass and the rates of bone loss among elderly Japanese-American men. Journal of Bone and Mineral Research, 12, 1495–501CrossRefGoogle Scholar
Wasnich, R. D. and Miller, P. D. (2000). Antifracture efficacy of antiresorptive agents are related to changes in bone density. Journal of Clinical Endocrinology and Metabolism, 85, 231–6CrossRefGoogle ScholarPubMed
Writing Group for the Women's Health Initiative Investigators (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principle results from the Women's Health Initiative Randomized Controlled Trial. Journal of the American Medical Association, 288, 321–33CrossRef

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×